Who receives DXA in VHA direct care vs. community care? Insights into bone health care for veterans.

Narla R, McCoy K, Mengeling MA, Davila H, Wysham K, Miller K, Solimeo SL. Who receives DXA in VHA direct care vs. community care? Insights into bone health care for veterans. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2026 Apr 1; 37(4):991-997, DOI: 10.1007/s00198-026-08025-2.

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.    Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions

Search for Abstract from PubMed

---

Abstract:

Veterans who choose to receive bone densitometry from a community clinic had less travel burden but may have experienced a longer time from referral to DXA. Ensuring access to DXA for accurate, timely diagnosis and to guide osteoporosis screening remains an important priority. PURPOSE: The Veterans Access, Choice, and Accountability Act (2014) expanded access to community-based dual-energy X-ray absorptiometry (DXA) for eligible veterans facing substantial travel burden or delays in VA access. We examined differences in travel burden, time from referral to DXA, and sociodemographic factors associated with receipt of VA-based DXA (VA-DXA) versus community DXA (CC-DXA) to understand the impact of this policy on veteran access to care. METHODS: We used mixed-effects logistic regression to estimate odds of receiving VA-DXA versus CC-DXA, from October 1, 2019-July 1, 2023, adjusting for clinical and demographic factors related to osteoporosis and access barriers. RESULTS: For veterans living  <  40 miles from a VA DXA site, CC-DXA recipients traveled shorter distances than VA-DXA recipients (median 6.6 vs. 13.8 miles); this difference widened for those  >  40 miles away from a VHA facility (7.0 vs. 60.7 miles). Conversely, VA-DXA had shorter elapsed time from referral to DXA regardless of proximity (e.g.,  <  40 miles: 24 vs. 39 days from referral). In adjusted models, living  >  40 miles from a tertiary VA facility was the strongest predictor of CC-DXA (aOR 4.86). CC-DXA use was more likely among female (aOR 1.60) and rural veterans (aOR 2.01) and among those with low/moderate frailty, and less likely among Black (aOR 0.50) and Asian veterans (aOR 0.57) compared with White veterans, and among Hispanic versus non-Hispanic veterans (aOR 0.84). CONCLUSIONS: CC-DXA reduced travel burden but was associated with longer referral-to-DXA time. Ongoing monitoring is warranted to ensure equitable, timely DXA access.